GTO ID |
GTD0325 |
Accession |
E-MTAB-11315
|
Gene therapy-related clinical trial |
GTC2404 |
Altered gene |
S |
Gene xrefs |
Gene ID:
1489668
|
Treatment |
ARCT-021(ARCT COVID-19 vaccine) |
Control |
Click to openARCT.101.1102.Day2_06;ARCT.101.1107.Day2_11;ARCT.101.2103.Day2_08;ARCT.101.2106.Day2_05;ARCT.101.2108.Day2_02;ARCT.101.2111.Day2_02;ARCT.101.3101.Day2_02;ARCT.101.3104.Day2_11;ARCT.101.4103.Day2_10;ARCT.101.4107.Day2_02;ARCT.101.4117.Day2_12;ARCT.101.4119.Day2_06;ARCT.101.5104.Day2_04;ARCT.101.5108.Day2_11;ARCT.101.5109.Day2_09;ARCT.101.5116.Day2_12;ARCT.101.6103.Day2_10;ARCT.101.6108.Day2_06;ARCT.101.6110.Day2_02;ARCT.101.6111.Day2_06;ARCT.101.7103.Day2_04;ARCT.101.7105.Day2_10;ARCT.101.7108.Day2_02;ARCT.101.7115.Day2_06;ARCT.101.8105.Day2_04;ARCT.101.8106.Day2_08;ARCT.101.8109.Day2_08;ARCT.101.8112.Day2_08 |
Case |
Click to openARCT.101.1101.Day2_02;ARCT.101.1103.Day2_10;ARCT.101.1104.Day2_02;ARCT.101.1105.Day2_05;ARCT.101.1106.Day2_09 |
Disease |
COVID-19 |
Disease information |
Disease group: Infection
Definition: A Coronavirus infection that is characterized by fever, cough and shortness of breath and that has_material_basis_in SARS-CoV-2.
Xref:
DO:0080600
|
Organism |
Homo sapiens |
Tissue/Cell type |
blood |
Characteristics |
Day2;1 microgram |
Strategy |
Microarray |
Platform |
A-MTAB-668 |